- Home
- Publications
- Publication Search
- Publication Details
Title
Prodrug Applications for Targeted Cancer Therapy
Authors
Keywords
cancer, complementation, conditional bispecificity, prodrugs, targeted therapy
Journal
AAPS Journal
Volume 16, Issue 5, Pages 899-913
Publisher
American Association of Pharmaceutical Scientists (AAPS)
Online
2014-07-09
DOI
10.1208/s12248-014-9638-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas
- (2013) P. E. Massa et al. BLOOD
- Engineering Anthrax Toxin Variants That Exclusively Form Octamers and Their Application to Targeting Tumors
- (2013) Damilola D. Phillips et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Complementation of the Catalytic Domain of Pseudomonas Exotoxin A
- (2013) Erin L. Boland et al. JOURNAL OF MOLECULAR BIOLOGY
- Receptor-Directed Chimeric Toxins Created by Sortase-Mediated Protein Fusion
- (2013) A. J. McCluskey et al. MOLECULAR CANCER THERAPEUTICS
- Synthesis and characterization of a new multifunctional polymeric prodrug paclitaxel–polyphosphoester–folic acid for targeted drug delivery
- (2013) Guoyi Zhang et al. Polymer Chemistry
- Neural Stem Cell-Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies
- (2013) K. S. Aboody et al. Science Translational Medicine
- Quantitative analysis of affinity enhancement by noncovalently oligomeric ligands
- (2012) Gregory M.K. Poon ANALYTICAL BIOCHEMISTRY
- Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer
- (2012) G R Simpson et al. BRITISH JOURNAL OF CANCER
- Molecular Mechanisms of Cardiotoxicity Induced by ErbB Receptor Inhibitor Cancer Therapeutics
- (2012) Anne-Sophie Hervent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Tumor-binding prodrug micelles of polymer–drug conjugates for anticancer therapy in HeLa cells
- (2012) Bokyung Jung et al. JOURNAL OF MATERIALS CHEMISTRY
- Dual Targeting of Hypoxic and Acidic Tumor Environments with a Cobalt(III) Chaperone Complex
- (2012) Natsuho Yamamoto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen
- (2012) Andrew J. McCluskey et al. Molecular Oncology
- Changing the Receptor Specificity of Anthrax Toxin
- (2012) A. Mechaly et al. mBio
- Protease-Activated Drug Development
- (2012) Ki Young Choi et al. Theranostics
- Prodrugs for improving tumor targetability and efficiency
- (2011) Rubi Mahato et al. ADVANCED DRUG DELIVERY REVIEWS
- Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers
- (2011) Andrew D. Wong et al. ADVANCED DRUG DELIVERY REVIEWS
- Chemical Dissection of Protein Translocation through the Anthrax Toxin Pore
- (2011) Brad L. Pentelute et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting hypoxic tumour cells to overcome metastasis
- (2011) Kevin L Bennewith et al. BMC CANCER
- Oncolytic Herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation
- (2011) S Yamada et al. CANCER GENE THERAPY
- Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox
- (2011) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Prodrugs for Targeted Tumor Therapies: Recent Developments in ADEPT, GDEPT and PMT
- (2011) Lutz F. Tietze et al. CURRENT PHARMACEUTICAL DESIGN
- A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia
- (2011) F. Bouquet et al. JOURNAL OF CELL SCIENCE
- A Semisynthesis Platform for Investigating Structure−Function Relationships in the N-Terminal Domain of the Anthrax Lethal Factor
- (2010) Brad L. Pentelute et al. ACS Chemical Biology
- Acycloguanosyl 5′-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice
- (2010) Simone Polvani et al. GASTROENTEROLOGY
- Bispecific antibodies for cancer therapy
- (2010) Patrick Chames et al. mAbs
- The Synthesis of a c(RGDyK) Targeted SN38 Prodrug with an Indolequinone Structure for Bioreductive Drug Release
- (2010) Baohua Huang et al. ORGANIC LETTERS
- A New Drug Delivery Method of Bispecific Ligand-Directed Toxins, Which Reduces Toxicity and Promotes Efficacy in a Model of Orthotopic Pancreatic Cancer
- (2010) Seunguk Oh et al. PANCREAS
- Transcriptional targeting of tumor endothelial cells for gene therapy
- (2009) Zhihong Dong et al. ADVANCED DRUG DELIVERY REVIEWS
- Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer
- (2009) Yi Lu ADVANCED DRUG DELIVERY REVIEWS
- Extending Thymidine Kinase Activity to the Catalytic Repertoire of Human Deoxycytidine Kinase†‡
- (2009) Saugata Hazra et al. BIOCHEMISTRY
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
- (2009) Laurent Ducry et al. BIOCONJUGATE CHEMISTRY
- Satraplatin: leading the new generation of oral platinum agents
- (2009) Ashish Bhargava et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives
- (2009) Eun Ju Oh et al. JOURNAL OF CONTROLLED RELEASE
- The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes
- (2009) Alexander F. Kintzer et al. JOURNAL OF MOLECULAR BIOLOGY
- Polymer-drug conjugates: Recent development in clinical oncology
- (2008) Chun Li et al. ADVANCED DRUG DELIVERY REVIEWS
- Design and synthesis of a β-lactamase activated 5-fluorouracil prodrug
- (2008) Ryan M. Phelan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
- (2008) Yashveer Singh et al. CURRENT MEDICINAL CHEMISTRY
- Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing Device
- (2008) Shanta Dhar et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phototoxic aptamers selectively enter and kill epithelial cancer cells
- (2008) Cátia S. M. Ferreira et al. NUCLEIC ACIDS RESEARCH
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
- (2008) S. Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- (2007) Sumitra Mukhopadhyay et al. BIOCONJUGATE CHEMISTRY
- Prodrug Strategies in Anticancer Chemotherapy
- (2007) Felix Kratz et al. ChemMedChem
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now